Search for: "United States v. James Read" Results 1521 - 1540 of 1,674
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Nov 2020, 12:18 pm by fjhinojosa
Gonzalez is cited in the following case: Kim Cramton v. [read post]
1 Jul 2015, 7:34 am by Schachtman
United States[13], the district court refused to enforce plaintiff’s Rule 45 subpoena that sought documents from defendant’s expert witness. [read post]
3 May 2020, 6:30 am by Guest Blogger
That would be fitting, because if this fine book is ultimately about one thing, it surely would be debate itself—the deep and fundamental debate that roiled the early United States and transformed it into a new kind of constitutional republic. [read post]
20 Jun 2023, 7:09 pm by Jacob Fishman
Part V concludes with a report card on how the regime is doing on its thirtieth anniversary. [read post]
23 Sep 2016, 7:49 am by Victoria Kwan
Shifting our review to the United States, Justice Sonia Sotomayor read the Declaration of Independence for Heritage Day at the Oysterponds Historical Society in Orient, New York. [read post]
17 Feb 2015, 4:17 am by Kevin LaCroix
As FBI Director James Comey eloquently put it, “There are two kinds of big companies in the United States. [read post]
15 Mar 2010, 2:09 pm by Robinson, Calcagnie & Robinson
In the process, these changes have saved lives here in the United States and abroad, and prevented countless injuries. [read post]
15 Nov 2023, 5:30 am by Josh Blackman
United States, which declared unconstitutional provisions of the Brady Act. [read post]
24 Dec 2023, 9:05 pm by The Regulatory Review
Nelson, Harvard Law School Businesses in the United States are increasingly supporting regulation and regulators against judicial decisions curtailing agency authority. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at BIO: (Managing… [read post]
30 Oct 2007, 1:11 pm
In the media, we constantly read about how "closely divided" the Court is and about how many cases are decided by a vote of five-to-four. [read post]